Back to The Defense Digest
Mitochondria Are Trending. Here Is What That Means for Your Eyes.
Medically reviewed by Craig D. Fishman, MD — Board-Certified Ophthalmologist

Mitochondria Are Trending. Here Is What That Means for Your Eyes.

Mitochondria are everywhere right now. TikTok wellness creators are obsessed with them. Longevity podcasts will not stop talking about them. A March 2026 Northeastern University feature called mitochondria "the key to longevity." Your favorite supplement brands are racing to position themselves as "mitochondrial support." The mitochondrial moment is real.

But here is what nobody in the wellness world is talking about: your eyes might benefit from this science more than almost any other part of your body.

What Are Mitochondria, Actually?

Think of mitochondria as tiny power generators inside your cells. Each cell contains dozens to thousands of them, and they do one critical job: convert the food you eat into usable energy called ATP. No ATP, no cellular function. No energy, you get sick.

This energy production happens through a process called oxidative phosphorylation. Electrons move across the inner mitochondrial membrane, pumping protons and creating energy that cells use to do everything from repairing damage to maintaining vision to keeping neurons alive.

Why Do Your Eyes Care More Than Most Organs?

Your retina is one of the most metabolically active tissues in your entire body. Photoreceptors and retinal ganglion cells are essentially energy factories. They are constantly converting light into electrical signals, maintaining ion gradients, and fighting oxidative stress. All of this demands relentless ATP production.

The problem: mitochondrial function declines with age. Studies show ATP production can decline by up to 70 percent over a lifetime. For tissues that are already energy-hungry, this decline is catastrophic.

This is not theoretical. Mitochondrial dysfunction is implicated in glaucoma, age-related macular degeneration, diabetic retinopathy, and other serious eye conditions. Your eyes are screaming for cellular energy, and aging is turning down the dial.

What Does the Research Actually Show?

NAD+ is a crucial coenzyme for energy production. Your cells need it to generate ATP. As you age, NAD+ levels drop, and your mitochondria struggle to keep up. This is where NAD+ precursors like nicotinamide riboside come in.

In a 2026 study published in Diseases, researchers at the University of Catania assessed patients with glaucoma who received combined supplementation with nicotinamide riboside and berberine (an AMPK activator). Over six months, patients receiving this combination showed functional stabilization of visual field and structural preservation of the optic nerve fiber layer. The mechanism: nicotinamide riboside replenishes NAD+, which activates sirtuins and supports mitochondrial function in retinal ganglion cells, the exact cells that glaucoma attacks.

This is preliminary evidence in humans, not definitive proof. But it directly links NAD+ biology to functional preservation of vision.

CoQ10 is an electron carrier in the mitochondrial respiratory chain. It is directly involved in ATP synthesis. In a 2024 study published in Frontiers in Cellular Neuroscience, researchers at the Hong Kong Polytechnic University tested topical CoQ10 eyedrops (conjugated with vitamin E TPGS) in a diabetic mouse model of retinal damage.

The results were striking. CoQ10 treatment significantly alleviated neurodegeneration, increased photoreceptor and bipolar cell density, reduced glial reactivity, and enhanced mitochondrial function. The treatment essentially preserved retinal structure and function against diabetic damage by supporting mitochondrial energy production.

Again, this is an animal study, not human clinical data. But it demonstrates a direct link between CoQ10, mitochondrial function, and retinal cell survival.

A 2024 study published in Acta Neuropathologica Communications examined nicotinamide (NAM) delivery to retinal ganglion cells in a glaucoma model. Researchers found that nicotinamide provided significant neuroprotection, preserving dendritic integrity more effectively than traditional cell count measurements. The mechanism is clear: NAM restores NAD+ levels, which supports mitochondrial energy production in the exact cells glaucoma destroys.

One important caveat: most of this research is in animal models or preliminary human cohorts. Large, randomized controlled trials are still needed. But the directional evidence is consistent: mitochondrial support targets a real biological mechanism of retinal aging and disease.

What Does This Mean for You?

You cannot stop aging. But you can be proactive about how your cells age. If your retina is one of the most energy-hungry tissues in your body, then supporting cellular energy should be part of your long-term eye health strategy.

This is where products designed around mitochondrial support come in. Sight Guard contains nicotinamide riboside (an NAD+ precursor), CoQ10 (an electron carrier), and calcium pyruvate (an energy substrate). These ingredients work together to support cellular energy production and optic nerve health. If you are looking to protect your long-term vision at the cellular level, this approach is backed by the same mechanisms driving the broader longevity conversation.

The Bigger Picture

Your eyes are not isolated from the rest of your body. The mitochondrial science driving the longevity movement is not just about energy and athletics. It is about cellular resilience. Your retina ages the way your brain ages, your heart ages, your muscles age. The mechanisms are the same.

As mitochondrial health becomes mainstream, eye health should be part of that conversation. You do not need to wait for a glaucoma diagnosis or macular degeneration to start thinking about retinal energy. You can start now, with the same science that is fueling the longevity boom.

References

1. Visalli F, Cappellani F, Gagliano G, et al. Mitochondrial Resilience in Glaucoma: Targeting NAD Metabolism and Oxidative Stress in Retinal Ganglion Cell Degeneration with Nicotinamide Riboside and Berberine: Preliminary Clinical Evidence. Diseases. 2026;14(2):56. doi: 10.3390/diseases14020056

2. Lam CHI, Zuo B, Chan HHL, et al. Coenzyme Q10 eyedrops conjugated with vitamin E TPGS alleviate neurodegeneration and mitochondrial dysfunction in the diabetic mouse retina. Frontiers in Cellular Neuroscience. 2024;18:1404987. doi: 10.3389/fncel.2024.1404987

3. Kim M, Kim JY, Rhim WK, et al. Extracellular vesicle encapsulated nicotinamide delivered via a trans-scleral route provides retinal ganglion cell neuroprotection. Acta Neuropathologica Communications. 2024;12:65. doi: 10.1186/s40478-024-01777-0

4. Hui F, Williams PA. Vitamins and nutraceuticals in glaucoma research. European Journal of Ophthalmology. 2026;14(2). doi: 10.1177/11206721261419640

Disclaimer

FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Medical Disclaimer: The information provided in this article is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.

Ready to support your vision?

Sight Guard is formulated by a board-certified ophthalmologist to support cellular energy in the eye.*

Learn About Sight Guard